2000/707/EC: Commission Decision of 6 November 2000 on financial assistance from the Community for storage in France, Italy and the United Kingdom of antigen for production of foot-and-mouth disease vaccine and amending Decision 2000/112/EC (notified under document number C(2000) 3175)
Date: 2000-11-06
Institutions: European Commission
Subjects: EU Member State, EU aid, financial aid, foot-and-mouth disease, storage, vaccine

L 289/38

EN

Official Journal of the European Communities

16.11.2000

COMMISSION

COMMISSION DECISION

of 6 November 2000

on financial assistance from the Community for storage in France, Italy and the United Kingdom of
antigen for production of foot-and-mouth disease vaccine and amending Decision 2000/112/EC

(notified under document number C(2000) 3175)

(2000/707/EC)

THE COMMISSION OF THE EUROPEAN COMMUNITIES,

concluded between the Commission and Merial SAS, in
accordance with this Decision.

Having regard to the Treaty establishing the European
Community,

(4)

Having regard to Council Decision 90/424/EEC of 26 June
1990 on expenditure in the veterinary field (1), as last amended
by Council Regulation (EC) No 1258/1999 of 17 May 1999 on
the financing of the common agricultural policy (2), and in
particular Article 14 thereof,

Whereas:

(1)

(2)

(3)

By virtue of Council Decision 91/666/EEC of 11
December 1991 estasblishing Community reserves of
foot-and-mouth disease vaccines (3), as last amended by
Decision 1999/762/EC (4),
establishment of antigen
banks is part of
the Community's action to create
Community reserves of foot-and-mouth disease vaccine.

Article 3 of that Decision designates the Laboratoire de
pathologie bovine du Centre national d'études vétéri-
naires et alimentaires at Lyon in France and the Istituto
Zooprofilaticco Sperimentale di Brescia in Italy as
antigen banks holding Community reserves and provides
for procedures to designate other establishments as
antigen bank by Commission Decision.

the Commission desig-
By Decision 2000/111/EC (5)
nated Merial SAS, Pirbright, United Kingdom, as a third
antigen bank and made provisions for the transfer of
antigen from a bank no longer designated. The
Community financial contribution for the year 2000 is
subject of the contract on transfer and storage of antigen

(5)

(6)

(7)

(8)

(9)

Commission Decision 2000/112/EC detailing
the
distribution between antigen banks of antigen reserves
established within the framework of the Community
action concerning reserves of foot-and-mouth disease
vaccines and amending Decisions 93/590/EC and 97/
348/EC (6) with regard to the storage site of certain
quantities and strains of antigen applies since 1 February
2000. However the transfer of antigen from Pirbright
Institute for Animal Health to Merial SAS, Pirbright was
delayed for technical reasons and thereby Pirbright Insti-
tute for Animal Health, continued to provide to the
Community the services of an antigen bank until the
transfer was completed on 28 June 2000.

The functions and duties of these antigen banks are
specified in Article 4 of Decision 91/666/EEC and
community assistance must be conditional on accom-
plishment of these.

Community financial assistance should be granted to the
banks providing services to the Community to enable
them to carry out during 2000 the said functions and
duties.

For budgetary reasons the Community assistance should
be granted for a period of one year.

For financial control purposes Articles 8 and 9 of Regu-
lation (EC) No 1258/1999 should apply.

Commission Decision 2000/112/EC should be amended
in order to take account of
the delayed transfer of
antigen from Pirbright Institute For Animal Health to
Merial SAS, Pirbright, United Kingdom.

(1) OJ L 224, 18.8.1990, p. 19.
(2) OJ L 160, 26.6.1999, p. 103.
(3) OJ L 368, 31.12.1991, p. 21.
(4) OJ L 301, 24.11.1999, p. 6.
(5) OJ L 33, 8.2.2000, p. 19.

(6) OJ L 33, 8.2.2000, p. 21.

16.11.2000

EN

Official Journal of the European Communities

L 289/39

(10)

The measures provided for in this Decision are in
accordance with the opinion of the Standing Veterinary
Committee,

The Community's financial assistance shall be up to a
3.
maximum of EUR 15 000 for the period 1 January to 30 June
2000.

Article 4

HAS ADOPTED THIS DECISION:

Article 1

The Community shall grant France financial assistance for
foot-and-mouth

1.
the stocking of antigen for production of
disease vaccine.

2.
The Laboratoire de pathologie bovine du Centre national
d'études vétérinaires et alimentaires at Lyon in France shall hold
the stock of antigen to which paragraph 1 relates. The provi-
sions of Article 4 of Decision 91/666/EEC shall apply.

3.
The Community's financial assistance shall be up to a
maximum of EUR 30 000 for the period 1 January to 31
December 2000.

Article 2

The Community shall grant Italy financial assistance for
foot-and-mouth

1.
the stocking of antigen for production of
disease vaccine.

2.
The Istituto Zooprofilattico Sperimentale di Brescia in
Italy shall hold the stock of antigen to which paragraph 1
relates. The provisions of Article 4 of Decision 91/666/EEC
shall apply.

3.
The Community's financial assistance shall be up to a
maximum of EUR 30 000 for the period 1 January to 31
December 2000.

The Community's

financial assistance referred to in
1.
Article 1(3), Article 2(3) and Article 3(3)
shall be paid
following presentation, by the Member State concerned, of
supporting documents, which demonstrate
effective
completion of the tasks.

the

2.
The supporting documents referred to in paragraph 1
must be presented to the Commission before 1 March 2001
and they should include:

(a) technical

information on:

— the amount and type of antigen stored (storage records),
— storage equipment used (type, number and capacity of

tanks),

— security system in place (temperature control, anti-theft

measures),

— insurance arrangements (fire, accidents);

(b) financial information (completion of table as show in the

Annex).

Article 5

Articles 8 and 9 of Regulation (EC) No 1258/1999 shall apply
mutatis mutandis.

Article 6

In Article 3 of Decision 2000/112/EC the date of ‘1 February
2000’

is changed to ‘1 July 2000’.

Article 3

This Decision is addressed to the Member States.

Article 7

The Community shall grant the United Kingdom financial
the stocking of antigen for production of

1.
assistance for
foot-and-mouth disease vaccine.

2.
The Institute for Animal Health at Pirbright in the United
Kingdom shall hold the stock of antigen to which paragraph 1
relates. The provisions of Article 4 of Decision 91/666/EEC
shall apply.

Done at Brussels, 6 November 2000.

For the Commission

David BYRNE

Member of the Commission

L 289/40

EN

Official Journal of the European Communities

16.11.2000

ANNEX

FINANCIAL INFORMATION RELATED TO THE STORAGE OF ANTIGEN FOR PRODUCTION OF
FOOT-AND-MOUTH DISEASE VACCINE

Statement of costs

Reporting period from: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . to: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Reference No of Commission Decision providing financial assistance: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Name and address of beneficiary: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Category of costs

Amount for the period
(National currency) (1)

1. Staff

2. Capital equipement

3. Consumables

4. Insurance

5. Rental of premises

(1) All costs must be expressed in national currency.

Total

Certificate by the beneficiary

We certify that:

— the above costs were incurred in connection with the tasks defined in the Decision and were essential to the sound

performance of those tasks,

— they are genuine costs falling within the definition of reimbursable costs,
— all the documents supporting the costs are available for audit purposes.

Date:

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Name of technical director:

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Signature: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Date:

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Person financially responsible: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Signature: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .